APA (7th ed.) Citation

M, B., G, S., F, P., M, D. J., G, S., A, P., . . . M, M. (2025). Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes. Frontiers in endocrinology, 16, 1670266. https://doi.org/10.3389/fendo.2025.1670266

Chicago Style (17th ed.) Citation

M, Bassi, Spacco G, Pezzotta F, Di Jorgi M, Siri G, Pintabona A, Calevo MG, Minuto N, and Maghnie M. "Real-world Efficacy of MiniMed™780G Recommended Settings (glycemic Target 100 Mg/dL, Active Insulin Time 2 Hours) in Youth and Young Adults with Type 1 Diabetes." Frontiers in Endocrinology 16 (2025): 1670266. https://doi.org/10.3389/fendo.2025.1670266.

MLA (9th ed.) Citation

M, Bassi, et al. "Real-world Efficacy of MiniMed™780G Recommended Settings (glycemic Target 100 Mg/dL, Active Insulin Time 2 Hours) in Youth and Young Adults with Type 1 Diabetes." Frontiers in Endocrinology, vol. 16, 2025, p. 1670266, https://doi.org/10.3389/fendo.2025.1670266.